Malaysia’s BiotechCorp To Expand Health Care Work
This article was originally published in PharmAsia News
Executive Summary
Malaysian Biotechnology says it plans to expand its development capabilities to help it focus on health care biotechnology in addition to agricultural and industrial biotech work. BiotechCorp is funded by the Malaysian government to ensure a place for the country in biotech efforts. The expansion effort includes acquisition of technology platforms to allow the firm to step up development in each of its focus areas. The platforms are to be acquired by the end of the year, CEO Datuk Iskandar Mizal Mahmood said. (Click here for more
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.